{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:44:44Z","timestamp":1772135084966,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["MIDASNI2020- 5"],"award-info":[{"award-number":["MIDASNI2020- 5"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["3U24GM132013-02S2"],"award-info":[{"award-number":["3U24GM132013-02S2"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Serosurveillance provides a unique opportunity to quantify the proportion of the population that has been exposed to pathogens. Here, we developed and piloted Serosurveillance for Continuous, ActionabLe Epidemiologic Intelligence of Transmission (SCALE-IT), a platform through which we systematically tested remnant samples from routine blood draws in two major hospital networks in San Francisco for SARS-CoV-2 antibodies during the early months of the pandemic. Importantly, SCALE-IT allows for algorithmic sample selection and rich data on covariates by leveraging electronic health record data. We estimated overall seroprevalence at 4.2%, corresponding to a case ascertainment rate of only 4.9%, and identified important heterogeneities by neighborhood, homelessness status, and race\/ethnicity. Neighborhood seroprevalence estimates from SCALE-IT were comparable to local community-based surveys, while providing results encompassing the entire city that have been previously unavailable. Leveraging this hybrid serosurveillance approach has strong potential for application beyond this local context and for diseases other than SARS-CoV-2.<\/jats:p>","DOI":"10.1038\/s41467-021-23651-6","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T06:05:00Z","timestamp":1623391500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0354-4076","authenticated-orcid":false,"given":"Isobel","family":"Routledge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8253-6102","authenticated-orcid":false,"given":"Adrienne","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen","family":"Janson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keirstinne","family":"Turcios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Vinden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk","family":"Sujishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelina","family":"Coh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Besana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai-Kit","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Ying","family":"Oon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chui Mei","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6971-2060","authenticated-orcid":false,"given":"Cassandra","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan H. B.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Karlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Thornborrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0585-6230","authenticated-orcid":false,"given":"Michael J.","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Henrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Pak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8078-3898","authenticated-orcid":false,"given":"Jessica","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0287-9111","authenticated-orcid":false,"given":"Bryan","family":"Greenhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Rodriguez-Barraquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"23651_CR1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S0140-6736(16)30164-7","volume":"388","author":"CJE Metcalf","year":"2016","unstructured":"Metcalf, C. J. E. et al. Use of serological surveys to generate key insights into the changing global landscape of infectious disease. Lancet 388, 728\u2013730 (2016).","journal-title":"Lancet"},{"key":"23651_CR2","doi-asserted-by":"publisher","first-page":"e58989","DOI":"10.7554\/eLife.58989","volume":"9","author":"MJ Mina","year":"2020","unstructured":"Mina, M. J. et al. A global lmmunological observatory to meet a time of pandemics. eLife 9, e58989 (2020).","journal-title":"eLife"},{"key":"23651_CR3","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/S1473-3099(20)30631-9","volume":"21","author":"RK Arora","year":"2020","unstructured":"Arora, R. K. et al. SeroTracker: a global SARS-CoV-2 seroprevalence dashboard. Lancet Infect. Dis. 21, e75\u2013e76 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"23651_CR4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.abe6959","volume":"371","author":"KM Bubar","year":"2020","unstructured":"Bubar, K. M. et al. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science 371, 916\u2013921 (2020).","journal-title":"Science"},{"key":"23651_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0140-6736(17)30054-5","volume":"389","author":"CJE Metcalf","year":"2017","unstructured":"Metcalf, C. J. E., Mina, M. J., Winter, A. K. & Grenfell, B. T. Opportunities and challenges of a World Serum Bank \u2013 Authors\u2019 reply. Lancet 389, 252 (2017).","journal-title":"Lancet"},{"key":"23651_CR6","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3201\/eid2609.201840","volume":"26","author":"H Clapham","year":"2020","unstructured":"Clapham, H. et al. Seroepidemiologic study designs for determining SARS-COV-2 transmission and immunity. Emerg. Infect. Dis. 26, 1978\u20131978 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"23651_CR7","doi-asserted-by":"publisher","first-page":"e13211","DOI":"10.1371\/journal.pone.0013211","volume":"5","author":"D Bandaranayake","year":"2010","unstructured":"Bandaranayake, D. et al. Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS ONE 5, e13211 (2010).","journal-title":"PLoS ONE"},{"key":"23651_CR8","doi-asserted-by":"publisher","first-page":"12562","DOI":"10.1371\/journal.pone.0012562","volume":"5","author":"GL Gilbert","year":"2010","unstructured":"Gilbert, G. L. et al. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS ONE 5, 12562 (2010).","journal-title":"PLoS ONE"},{"key":"23651_CR9","doi-asserted-by":"crossref","unstructured":"Dowse, G. K. et al. Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia - a seroprevalence study. Med. J. Aust. 194, 68\u201372 (2011).","DOI":"10.5694\/j.1326-5377.2011.tb04170.x"},{"key":"23651_CR10","doi-asserted-by":"publisher","first-page":"e48187","DOI":"10.1371\/journal.pone.0048187","volume":"7","author":"C Reed","year":"2012","unstructured":"Reed, C., Katz, J. M., Hancock, K., Balish, A. & Fry, A. M. Prevalence of seropositivity to pandemic influenza A\/H1N1 virus in the United States following the 2009 pandemic. PLoS ONE 7, e48187 (2012).","journal-title":"PLoS ONE"},{"key":"23651_CR11","doi-asserted-by":"crossref","unstructured":"Waalen, K. et al. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Eurosurveillance 15, 19633 (2010).","DOI":"10.2807\/ese.15.31.19633-en"},{"key":"23651_CR12","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3201\/eid1811.120720","volume":"18","author":"K Hoschler","year":"2012","unstructured":"Hoschler, K. et al. Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011. Emerg. Infect. Dis. 18, 1894\u20131897 (2012).","journal-title":"Emerg. Infect. Dis."},{"key":"23651_CR13","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/jmv.21895","volume":"82","author":"GC Mak","year":"2010","unstructured":"Mak, G. C. et al. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong. J. Med. Virol. 82, 1809\u20131815 (2010).","journal-title":"J. Med. Virol."},{"key":"23651_CR14","doi-asserted-by":"crossref","unstructured":"Havers, F. P. et al. Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020. JAMA Intern. Med. 180, 1576\u20131586 (2020).","DOI":"10.1001\/jamainternmed.2020.4130"},{"key":"23651_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533\u2013534 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"23651_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18468-8","volume":"11","author":"DL Ng","year":"2020","unstructured":"Ng, D. L. et al. SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood. Nat. Commun. 11, 4698 (2020).","journal-title":"Nat. Commun."},{"key":"23651_CR17","doi-asserted-by":"publisher","unstructured":"Chamie, G. et al. Community transmission of severe acute respiratory syndrome coronavirus 2 disproportionately affects the latinx population during shelter-in-place in San Francisco. Clin. Infect. Dis.\u00a0Aug 21, ciaa1234, https:\/\/doi.org\/10.1093\/cid\/ciaa1234 (2020).","DOI":"10.1093\/cid\/ciaa1234"},{"key":"23651_CR18","doi-asserted-by":"publisher","unstructured":"Appa, A. et al. Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community. Open Forum Infect. Dis. https:\/\/doi.org\/10.1093\/ofid\/ofaa531 (2020).","DOI":"10.1093\/ofid\/ofaa531"},{"key":"23651_CR19","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1007\/s11606-020-06081-w","volume":"35","author":"CP Gross","year":"2020","unstructured":"Gross, C. P. et al. Racial and ethnic disparities in population-level Covid-19 mortality. J. Gen. Intern. Med. 35, 3097\u20133099 (2020).","journal-title":"J. Gen. Intern. Med."},{"key":"23651_CR20","doi-asserted-by":"publisher","first-page":"100404","DOI":"10.1016\/j.eclinm.2020.100404","volume":"23","author":"D Pan","year":"2020","unstructured":"Pan, D. et al. The impact of ethnicity on clinical outcomes in COVID-19: a systematic review. EClinicalMedicine 23, 100404 (2020).","journal-title":"EClinicalMedicine"},{"key":"23651_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","volume":"588","author":"T Takahashi","year":"2020","unstructured":"Takahashi, T. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588, 315\u2013320 (2020).","journal-title":"Nature"},{"key":"23651_CR22","doi-asserted-by":"crossref","unstructured":"Cooch, P. B. et al.\u00a0 Supervised self-collected SARS-Cov-2 testing in classroom-based summer camps to inform safe in-person learning.\u00a0Journal of Pediatrics, Perinatology and Child Health,\u00a05, 075\u2013093 (2021).","DOI":"10.26502\/jppch.74050065"},{"key":"23651_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18468-8","volume":"11","author":"DL Ng","year":"2020","unstructured":"Ng, D. L. et al. SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood. Nat. Commun. 11, 4698 (2020).","journal-title":"Nat. Commun."},{"key":"23651_CR24","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/S0140-6736(20)32009-2","volume":"6","author":"S Anand","year":"2020","unstructured":"Anand, S. et al. Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet 6, 1335\u20131344 (2020).","journal-title":"Lancet"},{"key":"23651_CR25","doi-asserted-by":"publisher","first-page":"112832","DOI":"10.1016\/j.jim.2020.112832","volume":"484","author":"V Roy","year":"2020","unstructured":"Roy, V. et al. SARS-CoV-2-specific ELISA development. J. Immunol. Methods 484, 112832 (2020).","journal-title":"J. Immunol. Methods"},{"key":"23651_CR26","doi-asserted-by":"publisher","unstructured":"Geralovina, I. EPPIcenter\/flexfit: Flexible format standard curve fitting and data processing, Repository: https:\/\/github.com\/EPPIcenter\/flexfit (https:\/\/doi.org\/10.5281\/zenodo.4706072) (2021).","DOI":"10.5281\/zenodo.4706072"},{"key":"23651_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.12688\/wellcomeopenres.14950.2","volume":"4","author":"L Wu","year":"2020","unstructured":"Wu, L. et al. Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology. Wellcome Open Res. 4, 26 (2020).","journal-title":"Wellcome Open Res."},{"key":"23651_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0167-5877(00)00119-7","volume":"45","author":"IA Gardner","year":"2000","unstructured":"Gardner, I. A., Stryhn, H., Lind, P. & Collins, M. T. Conditional dependence between tests affects the diagnosis and surveillance of animal diseases. Prev. Vet. Med. 45, 107\u2013122 (2000).","journal-title":"Prev. Vet. Med."},{"key":"23651_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.32614\/RJ-2013-014","volume":"5","author":"D Kahle","year":"2013","unstructured":"Kahle, D. & Wickham, H. ggmap: Spatial Visualization with ggplot2. R. J. 5, 144\u2013161 (2013).","journal-title":"R. J."},{"key":"23651_CR30","unstructured":"R. Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, 2017)."},{"key":"23651_CR31","unstructured":"Stan Development Team. Stan Modeling Language Users Guide and Reference Manual. https:\/\/mc-stan.org (2020)."},{"key":"23651_CR32","doi-asserted-by":"publisher","unstructured":"Routledge, I.,\u00a0 Epstein, A. & Takahashi, S. Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records,\u00a0Repository:\u00a0www.github.com\/EPPIcenter\/scale-it (https:\/\/doi.org\/10.5281\/zenodo.4695335) (2021).","DOI":"10.5281\/zenodo.4695335"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23651-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:01:59Z","timestamp":1669968119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23651-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["23651"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-23651-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-180966\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"28 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3566"}}